Laboratory evaluation revealed reduced von Willebrand factor activity, consistent with acquired von Willebrand disease, presumed secondary to extreme thrombocytosis resulting in shear-induced proteolysis of von Willebrand factor multimers. The gene discussed is VWF; the disease is Thrombocytosis.